Aegon Ltd (A1EG34) Fair Value & Analysis
Financial Services · BR · Market cap R$66.5B
Fair value as of: Jul 13, 2026
From 24 valuation models · updated yesterday
Fair value updated Jul 13, 2026 — revised from R$12.99 to R$77.58 (+497.2%) since Jun 26, 2026. Share price −8.9% over the past month.
Price vs Fair Value (12 months)
12‑month range R$32.80 – R$49.40 · fair‑value band R$58.18 – R$96.97 · the R$45.00 price screens below the R$77.58 fair value. As of Jul 13, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Aegon Ltd (A1EG34) currently trades at R$45.00, while our model-based Fair Value estimate is R$77.58 — implying the stock looks roughly 72.4% undervalued today. We read business quality at 57/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Aegon Ltd generated revenue of R$12.2B at a net margin of 8.0%. Revenue declined 13.7% year over year. It earns a return on equity of 10.4%. Net debt stands at R$809M. Fundamentals as of Jul 13, 2026
Our scenario range runs from R$58.18 (bear case) to R$96.97 (bull case); at R$45.00, the current price sits below that range. The share trades near its 52-week high and 33% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -5% fair-value upside — at 72%, A1EG34 screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 13, 2026. TTM = trailing twelve months.
About the company
Aegon Ltd. provides insurance services in the Americas, the Netherlands, the United Kingdom, and internationally. It offers retirement plans, mutual funds, and unit-linked products; and annuities, life, and health insurance. The company provides its products under the Transamerica and World Financial Group brands. Aegon Ltd. was founded in 1844 and is based in Schiphol, the Netherlands.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Aegon Ltd reported revenue of R$13.1B in FY2025 versus R$42.5B in FY2021, a compound −25.5%/yr. Reported net income was R$977M in FY2025, compounding −16.2%/yr from FY2021.
Is A1EG34 fairly valued? → Check now
Similar stocks
10 more Insurance - Diversified stocks, each showing price versus our Fair Value estimate (as of Jul 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Berkshire Hathaway Inc BRKB | $492.81 | $556.10 | +13% |
| Allianz SE 1ALV | €420.00 | €397.72 | -5% |
| Zurich Insurance Group ZURVY | $36.15 | $29.58 | -18% |
| AXA SA AXAN | 795.49 MXN | 1,003 MXN | +26% |
| Assicurazioni Generali S.p.A ARZGY | $24.42 | $19.59 | -20% |
| Sun Life Financial Inc SLF | $77.50 | $61.89 | -20% |
| American International Group AIG | $73.44 | $58.77 | -20% |
| The Hartford Insurance Group H1IG34 | R$727.00 | R$237.89 | -67% |
| Talanx AG TLLXY | $60.33 | $109.48 | +81% |
| Arch Capital Group ACGL | $88.34 | $176.68 | +100% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Aegon Ltd (A1EG34) undervalued?
What is the fair value of A1EG34?
What is the quality score of A1EG34?
What is the revenue of Aegon Ltd (A1EG34)?
What is the net profit margin of A1EG34?
Does Aegon Ltd pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Aegon Ltd analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.